Brief: Diamyd Medical To Be Granted Precision Medicine Patent

Diamyd Medical AB

06/12/2022 12:49

Dec 6 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * DIAMYD MEDICAL PRECISION MEDICINE PATENT FOR PREVENTION
AND
TREATMENT OF AUTOIMMUNE DIABETES TO BE GRANTED IN EURASIA
    * PATENT TO BE GRANTED BY EURASIAN PATENT OFFICE IS VALID
UNTIL
2035
    * PRIMARILY PROTECTS USE OF A GAD AUTOANTIGEN TO TREAT OR
PREVENT
AUTOIMMUNE DIABETES IN INDIVIDUALS CARRYING HLA DR3-DQ2 GENE

Source text for Eikon:  ID:nWkr3mhlNP 
Further company coverage:  DMYDb.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))